Matches 1 - 50 out of 177 1 2 3 4 >
Match Document Document Title
7384941 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors  
Compounds of formula (I): wherein A is S or O; R is H; Ar is an optionally substituted phenyl group; X is an optionally substituted phenyl group, a C 1 -C 4 alkyl, a C 3 -C 6 cycloalkyl...
7378446 Compound having anti-HCV activity and process for producing the same  
The object of the present invention is to provide a compound useful for the prevention and treatment of viral infectious diseases, and particularly liver diseases caused by HCV infection due to its...
7338953 Method of treating chronic fatigue syndrome  
Disclosed herein are methods of treating an individual suffering from, chronic fatigue syndrome. The methods generally include administration of a therapeutic amount of racemic reboxetine, or a...
7317011 Method of treating peripheral neuropathy  
Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of optically pure (S,S) reboxetine,...
7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives  
The present invention provides compounds of the structure: wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases...
7294623 Benzyl morpholine derivatives  
A compound of formula (I) (I) wherein R is H; Ar is an aromatic group selected from phenyl; X is a phenyl group; R′ is H or C1-C4 alkyl; each R1 is independently H or C1-C4 alkyl; and...
7141560 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics  
The present invention relates to alanine 2,6-dialkoxyphenyl ester derivatives having the general formula I The invention also relates to pharmaceutical compositions comprising said derivatives,...
6987107 Method of treating incontinence  
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of...
6964963 Preparation of 4-amino-1-naphthol ethers  
The present invention describes a process for preparing 4-amino-1-naphthol ethers which is characterized in that naphthol ethers are first prepared from 1-naphthols, the former are then converted...
6964962 Combinations of reboxetine and neuroleptic agents  
A composition comprising: (a) a pharmaceutically effective amount of reboxetine; and selected from the group consisting of clozapine, olanzapine, risperidone and mixtures thereof (b) a...
6900203 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them  
(R)-6F-phenylephrine, essentially free of (S)-6F-phenylephrine, and an anesthetic formulation comprising (R)-6F-epinephrin or (R)-6F-phenylephrine and having improved stability compared to...
6878706 Cyanamides useful as reversible inhibitors of cysteine proteases  
Compounds according to the following formula (I): wherein the variables Q and R 1 to R 6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F,...
6787543 Benzhydryl derivatives  
A compound of the formula (I): in which Z, R 1 , R 2 , R 8 , R 10 , R 11 , R 12 , R 13 and R 14 are each as defined in the description, or a salt thereof. The object compound of the present...
6703389 Method of treating chronic pain  
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of...
6642235 Method of treating migraine headaches with a highly selective noreoinephrine reuptake inhibitor  
Methods for treating humans suffering from, migraine headaches by inhibiting reuptake of norepinephrine are disclosed. The methods comprise a compound having a pharmacological selectivity of...
6610690 Method of treating or preventing fibromyalgia and other somatoform disorders with a highly selective norepinephrine reuptake inhibitor  
This application relates to methods for treating humans suffering from, fibromyalgia or other somatoform disorders where inhibiting reuptake of norepinephrine is a benefit. The methods comprise a...
6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives  
The present invention relates to compounds of the formula I, wherein Z 1 , Z 2 , X, Q, R 1 , R 2 and R 3 are defined as in the specification, pharmaceutical compositions containing such...
6586427 Treatments for nervous disorders  
This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and...
6541523 Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine  
The present invention relates to methods and compositions comprising a very low dose of cyclobenzaprine or metabolite thereof for preventing and treating sleep disturbances and illnesses manifested...
6541471 Benzenesulphonamide compounds  
A compound of formula (I): wherein: G represents a group such as: wherein R 1 and R 2 independently represent a hydrogen atom or an alkyl, cycloalkyl, aryl, arylalkyl, cycloalkyl,...
6500827 Drug combinations  
This patent application describes a new combination treatment of selective, noradrenaline-reuptake inhibitors (NARI) and specifically, reboxetine, and pindolol to provide rapid relief to patients...
6500826 Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract  
The use of panaverium bromide for treating or preventing diseases of the liver and digestive tract caused by excessive cell proliferation therein, is disclosed.
6479491 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists  
The present invention relates to compounds of formula (I), any of it enantiomers, or any mixture thereof, or a pharmaceutically acceptable acid addition salt thereof, wherein R 1 , R 2 , R 3 , R 4...
6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor  
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of...
6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides  
Fungicidal compounds of formula (I): wherein W is CH 3 O.CH═CCO 2 CH 3 , CH 3 ON═CCONR 3 R 4 or CH 3 ON═CCO 2 CH 3 and stereoisomers thereof; n is 0 or 1; X is oxygen or sulphur; Z is NR...
6458781 Substituted diarylalkyl amides as calcium channel antagonists  
The present invention provides compounds that block calcium channels and have the Formula I: The present invention also provides pharmaceutical compositions containing the compounds of Formula I...
6451817 Alpha-substituted-1-benzyl-napthyls  
This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 1-benzyl-naphthyls which are α-substituted with ether, thioether, amino, hydrazino, cyano or halo...
6441038 Treatment of fatigue, head injury and stroke  
A method of treatment of disorders of neurological origin and drug formulations for use in the method are disclosed. These conditions comprise fatigue and associated syndromes of pain, weakness and...
6413961 Irrigation solution and method for inhibition of pain and inflammation  
A method and solution for perioperatively inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general surgical, therapeutic and diagnostic...
6391892 Naphthyl pharmaceutical compounds  
The present invention provides a compound of formula I wherein R 1 is H, OH, halo, OCO(C 1 -C 6 alkyl), OCO(aryl), OSO 2 (C 4 -C 6 alkyl), OCOO(C 1 -C 6 alkyl), OCOO(aryl), OCONH(C 1 -C 6 ...
6391876 Reboxetine for treatment obsessive compulsive disorders and panic disorder  
This invention relates to the use of reboxetine in the treatment of Obsessive Compulsive Disorders and Panic Disorders.
6384053 α-substituted-1-benzyl-napthyls  
This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 1-benzyl-naphthyls which are α-substituted with ether, thioether amino, cyano or halo that are...
6365131 Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic  
Pharmaceutical dental gel preparation comprising of metronidazole benzoate, chlorhexidine gluconate, and local anesthetic as the active ingredient; glycol as the solvent medium; a carboxyvinyl...
6284799 Cancer treatment  
The present invention is concerned with the identification of compounds which increase the therapeutic index of chemotherapy drugs and which stimulate the growth of cancers, their use in the...
6184222 Treatment of conduct disorder  
Norepinephrine reuptake inhibitors are used to treat conduct disorder.
6177427 Treatment of glaucoma and ocular hypertension  
Compositions of non-steroidal glucocorticoid antagonists for treating glaucoma or ocular hypertension and methods for their use are disclosed.
6177067 Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof  
Disclosed is a hair revitalizing tonic composition containing a dimethylpropanediol derivative of the formula: ##STR1## wherein R 1 and R 2 are each independently a C 1 -30 hydrocarbon group...
6051573 Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists  
Compositions of non-steroidal glucocorticoid antagonists for treating GLC1A glaucoma and methods for their use are disclosed.
6046193 Treatment of attention-deficit/hyperactivity disorder  
Reboxetine is used to treat attention-deficit/hyperactivity disorder.
6028070 Treatment of oppositional defiant disorder  
Norepinephrine reuptake inhibitors are used to treat oppositional defiant disorder.
6017918 Phenyl glycine compounds and methods of treating atherosclerosis and restenosis  
The present invention provides compounds having the Formula I ##STR1## The present invention also provides methods of treating atherosclerosis, coronary heart disease, and restenosis using the...
6013649 Thiol sulfone metalloprotease inhibitors  
This invention is directed to proteinase (protease) inhibitors, and more particularly to thiol sulfone inhibitors for matrix metalloproteinase 13(MMP-13), compositions of proteinase inhibitors,...
5962507 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds, and their use, as well as a method of preparing them  
Compounds that inhibit the enzyme 2,3-epoxysqualene-lanosterol-cyclase and cholesterol biosynthesis, of the formula I ##STR1## wherein n denotes the number 0 or 1, m denotes the number 1 or 2, p...
5958917 Benzofluorene compounds, intermediates, compositions, and methods  
The present invention provides compounds of formula I ##STR1## wherein R 1 is --H, --OH, --O(C 1 -C 4 alkyl), --OCO(C 1 -C 6 alkyl), --OCOO(C 1 -C 6 alkyl), --OCOAr, --OCOOAr, or --OSO 2 (C...
5914340 Leukotriene antagonists useful for treating dermatoses  
This invention provides methods for the treatment or inhibiting of dermatitis which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a...
5872117 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same  
This invention relates to a 1,2-ethanediol derivative and a salt thereof, a process for producing the same, and a cerebral function-improving agent comprising the same. The cerebral...
5869484 Phenylcarbamate derivatives suitable to the use as anticholinesterase substances  
Phenylcarbamate derivatives suitable to the use as anticholinesterase substances having the general formula (I) ##STR1## wherein the meaning of R 1 -R 7 and X substituentes together with n will...
5859065 Treatment method for cancer  
The in vivo chemotherapeutic treatment of cancer cells in a living animal is improved by first administering to the animal, a compound which inhibits normal cell proliferation while promoting...
5821253 Tetrahydrobenzo a!fluorene compounds and methods of use  
The invention provides tetrahydrobenzo a!fluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological...
5817684 Leukotriene antagonists for use in the treatment or inhibition of cerebral focal stroke  
This invention provides methods for the treatment or prevention of cerebral focal ischemia which comprises administering to a mammal in need thereof an effective amount of a compound having...
Matches 1 - 50 out of 177 1 2 3 4 >